Business Description
Hester Biosciences Ltd
ISIN : INE782E01017
Total Employee Number:
562Compare
Compare
Traded in other countries / regions
524669.India IPO Date
1994-10-31Description
Hester Biosciences Ltd is an India-based animal healthcare company. It is principally engaged in the manufacturing of veterinary vaccines and trading of veterinary health products such as goat pox vaccine, PPR vaccines, etc. The group has two principal operating and reporting segments, viz. Poultry healthcare and Animal healthcare. Maximum revenue is generated from the Poultry Healthcare segment, which offers various solutions encompassing vaccines, health products, and feed supplements, supported and packaged by its diagnostic services, R&D, quality standards, and field support, to help farmers protect flock health, enhance productivity, and drive long-term farm sustainability. Geographically, it generates maximum revenue within India, and also exports its products to other markets.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.54 | |||||
Debt-to-EBITDA | 1.84 | |||||
Interest Coverage | 6.2 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 5.5 | |||||
Beneish M-Score | -2.31 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.7 | |||||
3-Year EBITDA Growth Rate | 15.7 | |||||
3-Year EPS without NRI Growth Rate | 29.7 | |||||
3-Year Book Growth Rate | 8.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.75 | |||||
9-Day RSI | 61.71 | |||||
14-Day RSI | 62.28 | |||||
3-1 Month Momentum % | 32.99 | |||||
6-1 Month Momentum % | 53.74 | |||||
12-1 Month Momentum % | 19.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.37 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 309.93 | |||||
Days Sales Outstanding | 95.54 | |||||
Days Payable | 122.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.44 | |||||
Dividend Payout Ratio | 0.11 | |||||
3-Year Dividend Growth Rate | -11.2 | |||||
Forward Dividend Yield % | 0.44 | |||||
5-Year Yield-on-Cost % | 0.36 | |||||
Shareholder Yield % | 1.68 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75.36 | |||||
Operating Margin % | 20.38 | |||||
Net Margin % | 16.73 | |||||
EBITDA Margin % | 31.77 | |||||
FCF Margin % | 13.92 | |||||
OCF Margin % | 19.28 | |||||
ROE % | 16.49 | |||||
ROA % | 8.32 | |||||
ROIC % | 8.3 | |||||
3-Year ROIIC % | 114.69 | |||||
ROC (Joel Greenblatt) % | 15.8 | |||||
ROCE % | 16.4 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 36.9 | |||||
PE Ratio without NRI | 38.24 | |||||
Shiller PE Ratio | 50.6 | |||||
Price-to-Owner-Earnings | 150.74 | |||||
PEG Ratio | 9.1 | |||||
PS Ratio | 6.16 | |||||
PB Ratio | 5.89 | |||||
Price-to-Tangible-Book | 6.05 | |||||
Price-to-Free-Cash-Flow | 45.8 | |||||
Price-to-Operating-Cash-Flow | 33.07 | |||||
EV-to-EBIT | 26.75 | |||||
EV-to-EBITDA | 21.97 | |||||
EV-to-Revenue | 6.98 | |||||
EV-to-FCF | 47.74 | |||||
Price-to-GF-Value | 1.31 | |||||
Price-to-Projected-FCF | 10.3 | |||||
Price-to-DCF (Earnings Based) | 4.12 | |||||
Price-to-DCF (FCF Based) | 4.93 | |||||
Price-to-Graham-Number | 3.21 | |||||
Earnings Yield (Greenblatt) % | 3.73 | |||||
FCF Yield % | 2.18 | |||||
Forward Rate of Return (Yacktman) % | 4.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hester Biosciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,325.99 | ||
| EPS (TTM) (₹) | 67.57 | ||
| Beta | 1.4421 | ||
| 3-Year Sharpe Ratio | 0.26 | ||
| 3-Year Sortino Ratio | 0.45 | ||
| Volatility % | 48.42 | ||
| 14-Day RSI | 62.28 | ||
| 14-Day ATR (₹) | 114.85317 | ||
| 20-Day SMA (₹) | 2347.0825 | ||
| 12-1 Month Momentum % | 19.28 | ||
| 52-Week Range (₹) | 1250.95 - 2661.65 | ||
| Shares Outstanding (Mil) | 8.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hester Biosciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hester Biosciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2027 | 2027-01-29 14:00 | In 184 days | ||
| Third quarter earnings results for 2027 | 2027-01-29 | In 183 days | ||
| Second quarter earnings conference call for 2027 | 2026-11-12 14:00 | In 106 days | ||
| Second quarter earnings results for 2027 | 2026-11-12 | In 105 days | ||
| First quarter earnings conference call for 2027 | 2026-07-30 14:00 | In 1 day | ||
| First quarter earnings results for 2027 | 2026-07-30 | 2,525.10 (-0.13%) | ||
| General meeting for 2026 | 2026-07-21 10:30 | 2,517.55 (+0.67%) | ||
| INR 11.000000 Cash Dividend | 2026-07-14 | 2,531.25 (+20.00%) | ||
| Annual report for 2026 | 2026-06-18 | 2,054.10 (-0.16%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-15 14:00 | 1,735.65 (+0.45%) |
Show
Entries
Hester Biosciences Ltd Frequently Asked Questions
What is Hester Biosciences Ltd(BOM:524669)'s stock price today?
The current price of BOM:524669 is ₹2493.65. The 52 week high of BOM:524669 is ₹2661.65 and 52 week low is ₹1250.95.
When is next earnings date of Hester Biosciences Ltd(BOM:524669)?
The next earnings date of Hester Biosciences Ltd(BOM:524669) is 2026-07-30.
Does Hester Biosciences Ltd(BOM:524669) pay dividends? If so, how much?
The Dividend Yield %  of Hester Biosciences Ltd(BOM:524669) is 0.44% (As of Today), Highest Dividend Payout Ratio of Hester Biosciences Ltd(BOM:524669) was 0.37. The lowest was 0.1. And the median was 0.2. The  Forward Dividend Yield % of Hester Biosciences Ltd(BOM:524669) is 0.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hester Biosciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers